Tag Archives: U.S.

Is Peanut Allergy ‘Immunotherapy’ Causing More Harm Than Good? – U.S. News & World Report

[unable to retrieve full-text content] Is Peanut Allergy ‘Immunotherapy’ Causing More Harm Than Good?  U.S. News & World Report Experimental treatment for peanut allergy increases anaphylaxis risk, study finds  CNN Oral peanut allergy treatment boosts anaphylaxis risk, says study  USA TODAY Peanut allergy immunotherapy may actually do more harm than good  New Scientist A Promising Peanut Allergy Treatment May… Read More »

U.S. House condemns Trump’s courtroom efforts to end Obamacare

WASHINGTON (Reuters) – Calling it an effort to take away Americans’ healthcare, the U.S. House of Representatives voted Wednesday to condemn the Trump administration’s courtroom bid to eliminate Obamacare. The 240-186 vote was a largely symbolic move aimed at keeping the spotlight on the issue. Just eight Republicans joined majority Democrats in voting to urge… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »